Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis (Q44065894)

29 November 2017

title

Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis (English)

1 reference

clinically isolated syndrome

29 November 2017

0 references

1 reference

8

1 reference

29 November 2017

D Chard

3

0 references

author name string

P Kapeller

1

1 reference

29 November 2017

P A Brex

2

1 reference

29 November 2017

C Dalton

4

1 reference

29 November 2017

C M Griffin

5

1 reference

29 November 2017

M A McLean

6

1 reference

29 November 2017

G J M Parker

7

1 reference

29 November 2017

D H Miller

9

1 reference

29 November 2017

publication date

1 May 2002

1 reference

Multiple Sclerosis Journal

29 November 2017

published in

1 reference

29 November 2017

volume

8

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

207-210

1 reference

The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Multisequence MRI in clinically isolated syndromes and the early development of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Imaging axonal damage of normal-appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

1H MRSI of normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Multinuclear NMR studies on the energy metabolism of glial and neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS822OA

10.1191/1352458502MS822OA

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference